I have more than 25 years of research and development experience in biotechnology and a co-founder of five biotech companies, one which is ArunA Biomedical, the first company to commercialize a product derived from human pluripotent stem cells and cell development that was used to facilitate approval of Pfizer’s current cognitive enhancing pharmaceuticals, and SciStem Inc., which I currently serve as Chief Scientific Officer. Today my research focus is mainly centered on the development of cell-based assays to support high-throughput chemical and compound screening.

I co-chair a seat on REM, Regenerative Engineering and Medicine — a partnership between: Emory University, Georgia Tech and UGA. I play an active leadership role in EBICS, Emergent Behaviors of Integrated Cellular Systems, a NSF Technology Center founded by MIT.